Herein, we found that L-carnitine supplementation significantly reduced the hepatic levels of IL-6, IL-1β and TNF-α and enhanced IL-10 compared to those in the NAFLD mice. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.